• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 4: Shah Mahesh was granted 79,750 shares and returned 170,733 shares to the company, closing all direct ownership in the company

    7/6/22 7:30:42 PM ET
    $CDK
    Retail: Computer Software & Peripheral Equipment
    Technology
    Get the next $CDK alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
    X
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
    1. Name and Address of Reporting Person*
    Shah Mahesh

    (Last) (First) (Middle)
    1950 HASSELL ROAD

    (Street)
    HOFFMAN ESTATES IL 60169-6308

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    CDK Global, Inc. [ CDK ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    Chief Product & Tech. Officer
    3. Date of Earliest Transaction (Month/Day/Year)
    07/06/2022
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 07/06/2022 A 79,750(1) A (1) 170,733 D
    Common Stock 07/06/2022 D 170,733 D (2) 0 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Option (right to buy) $55.35 07/06/2022 D 22,288 (3) (3) Common Stock 22,288 (3) 0 D
    Explanation of Responses:
    1. Represents shares of common stock, par value $0.01 per share (each, a "Share"), of CDK Global, Inc. (the "Company") that are subject to performance-based restricted stock units ("PSUs"). Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), among the Company, Central Parent LLC ("Parent") and Central Merger Sub Inc. ("Merger Sub"), on July 6, 2022 (the "Closing Date"), Merger Sub merged with and into the Company, with the Company surviving the merger as a wholly owned subsidiary of Parent (the "Merger"), and each PSU outstanding immediately prior to the consummation of the Merger became fully vested at the greater of the target and actual performance measured through the Closing Date (with the performance in respect of any fiscal year commencing after the 2022 fiscal year being at target performance), and was canceled and converted into the right to receive, for each Share subject to such then-vested PSU, $54.87 in cash without interest.
    2. Pursuant to the Merger Agreement, at the effective time of the Merger, each Share was canceled and converted into the right to receive $54.87 in cash without interest.
    3. Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the Merger, whether then unvested or vested, by virtue of the Merger and without any action by the holder, was canceled and converted into only the right to receive an amount in cash, without interest, equal to the product of (x) the number of Shares issuable under such option and (y) the excess, if any, of (i) $54.87 over (ii) the exercise price payable in respect of each Share issuable under such option (the "Option Consideration"); provided, however, that the Option Consideration for each option with an exercise price equal to or greater than $54.87 was $0.
    /s/ Lee J. Brunz, Power of Attorney 07/06/2022
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $CDK alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CDK

    DatePrice TargetRatingAnalyst
    12/16/2021$48.00Overweight → Equal-Weight
    Morgan Stanley
    8/18/2021$62.00 → $56.00Overweight
    Morgan Stanley
    More analyst ratings

    $CDK
    Leadership Updates

    Live Leadership Updates

    See more
    • Omnicell Elects Eileen Voynick to Board of Directors

      Sales and Operational Veteran Brings Additional Global Business Experience and Healthcare Technology Expertise to Board Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell" or the "Company"), a leader in transforming the pharmacy care delivery model, today announced that the Board of Directors elected Eileen Voynick to the Board, effective January 5, 2024. Ms. Voynick fills the vacancy resulting from Sara J. White, a Class I director who stepped down from the Company's Board of Directors, effective January 5, 2024. In addition, the Company announced that Vance Moore will not stand for reelection to the Company's Board at Omnicell's 2024 annual meeting of stockholders (the "2024 annual meeting") and e

      1/11/24 4:00:00 PM ET
      $MDRX
      $OMCL
      $CDK
      EDP Services
      Technology
      Computer Manufacturing
      Retail: Computer Software & Peripheral Equipment
    • AGS Health Welcomes Eileen Voynick as Board Chair

      OLYPHANT, Pa., April 8, 2021 /PRNewswire/ -- AGS Health, a leader in revenue cycle management solutions, today announced the appointment of Eileen Voynick as board chair. "I'm excited to join the AGS Health team at this pivotal time for growth," said Ms. Voynick. "I look forward to working closely with the leadership team in helping develop forward-thinking revenue cycle management strategies to achieve great results for healthcare providers, enabling them to invest further in care delivery," she noted. Eileen Voynick, AGS Health Board Chair With decades of experience in healthcare technology, life sciences and services, Ms. Voynick is an industry leader with a prove

      4/8/21 11:30:00 AM ET
      $CDK
      Retail: Computer Software & Peripheral Equipment
      Technology

    $CDK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by CDK Global Inc. (Amendment)

      SC 13G/A - CDK Global, Inc. (0001609702) (Subject)

      8/2/22 10:17:59 AM ET
      $CDK
      Retail: Computer Software & Peripheral Equipment
      Technology
    • SEC Form SC 13G filed by CDK Global Inc.

      SC 13G - CDK Global, Inc. (0001609702) (Subject)

      2/11/22 2:16:52 PM ET
      $CDK
      Retail: Computer Software & Peripheral Equipment
      Technology
    • SEC Form SC 13G/A filed by CDK Global Inc. (Amendment)

      SC 13G/A - CDK Global, Inc. (0001609702) (Subject)

      2/11/22 11:19:53 AM ET
      $CDK
      Retail: Computer Software & Peripheral Equipment
      Technology

    $CDK
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Omnicell Elects Eileen Voynick to Board of Directors

      Sales and Operational Veteran Brings Additional Global Business Experience and Healthcare Technology Expertise to Board Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell" or the "Company"), a leader in transforming the pharmacy care delivery model, today announced that the Board of Directors elected Eileen Voynick to the Board, effective January 5, 2024. Ms. Voynick fills the vacancy resulting from Sara J. White, a Class I director who stepped down from the Company's Board of Directors, effective January 5, 2024. In addition, the Company announced that Vance Moore will not stand for reelection to the Company's Board at Omnicell's 2024 annual meeting of stockholders (the "2024 annual meeting") and e

      1/11/24 4:00:00 PM ET
      $MDRX
      $OMCL
      $CDK
      EDP Services
      Technology
      Computer Manufacturing
      Retail: Computer Software & Peripheral Equipment
    • BringOz Joins CDK Global Partner Program

      BringOz, the world's most complete delivery management system, today announced that it has become a participant in the CDK Global Partner Program. As a member of one of the largest third-party partner programs in the industry. BringOz is now part of a marketplace of applications and integrations that CDK Global, Inc. (NASDAQ:CDK), a leading enabler of end-to-end automotive commerce, developed to help automotive dealers succeed. "Integrating BringOz' solution with CDK's dealer management system enables automotive dealerships to simplify and streamline delivery management, save time and resources, and offer an efficient, convenient, and transparent delivery experience that today's customers

      5/11/23 7:48:00 AM ET
      $CDK
      Retail: Computer Software & Peripheral Equipment
      Technology
    • Dealer Pay Joins CDK Global Partner Program

      Dealer Pay, whose Point-of-Sale solutions provide modern payment acceptance to both auto and truck dealerships, today announced that it has become a participant in the CDK Global Partner Program. As a member of one of the largest third-party partner programs in the industry, DealerPay is now part of a marketplace of applications and integrations that CDK Global, Inc. (NASDAQ:CDK), a leading automotive retail technology company, developed to help automotive dealers succeed. CEO, Julie Douglas affirms, "Dealer Pay is honored to join the CDK Global Partner Program." As a vendor, Dealer Pay will provide payment solutions that streamline the sales process and improve the customer experience. De

      12/15/22 12:26:00 PM ET
      $CDK
      Retail: Computer Software & Peripheral Equipment
      Technology

    $CDK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Voynick Eileen J. returned 22,827 shares to the company, closing all direct ownership in the company

      4 - CDK Global, Inc. (0001609702) (Issuer)

      7/6/22 7:31:54 PM ET
      $CDK
      Retail: Computer Software & Peripheral Equipment
      Technology
    • SEC Form 4: Tautges Joseph A was granted 103,073 shares and returned 231,834 shares to the company, closing all direct ownership in the company

      4 - CDK Global, Inc. (0001609702) (Issuer)

      7/6/22 7:31:28 PM ET
      $CDK
      Retail: Computer Software & Peripheral Equipment
      Technology
    • SEC Form 4: Shah Mahesh was granted 79,750 shares and returned 170,733 shares to the company, closing all direct ownership in the company

      4 - CDK Global, Inc. (0001609702) (Issuer)

      7/6/22 7:30:42 PM ET
      $CDK
      Retail: Computer Software & Peripheral Equipment
      Technology

    $CDK
    SEC Filings

    See more
    • SEC Form 15-12G filed by CDK Global Inc.

      15-12G - CDK Global, Inc. (0001609702) (Filer)

      7/18/22 9:00:24 AM ET
      $CDK
      Retail: Computer Software & Peripheral Equipment
      Technology
    • CDK Global Inc. filed SEC Form 8-K: Leadership Update

      8-K - CDK Global, Inc. (0001609702) (Filer)

      7/12/22 8:38:28 AM ET
      $CDK
      Retail: Computer Software & Peripheral Equipment
      Technology
    • SEC Form S-8 POS filed by CDK Global Inc.

      S-8 POS - CDK Global, Inc. (0001609702) (Filer)

      7/6/22 4:42:09 PM ET
      $CDK
      Retail: Computer Software & Peripheral Equipment
      Technology

    $CDK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • CDK Global downgraded by Morgan Stanley with a new price target

      Morgan Stanley downgraded CDK Global from Overweight to Equal-Weight and set a new price target of $48.00

      12/16/21 6:51:43 AM ET
      $CDK
      Retail: Computer Software & Peripheral Equipment
      Technology
    • Morgan Stanley reiterated coverage on CDK Global with a new price target

      Morgan Stanley reiterated coverage of CDK Global with a rating of Overweight and set a new price target of $56.00 from $62.00 previously

      8/18/21 7:37:39 AM ET
      $CDK
      Retail: Computer Software & Peripheral Equipment
      Technology
    • Oppenheimer reiterated coverage on CDK Global with a new price target

      Oppenheimer reiterated coverage of CDK Global with a rating of and set a new price target of $65.00 from $55.00 previously

      2/9/21 1:45:55 PM ET
      $CDK
      Retail: Computer Software & Peripheral Equipment
      Technology

    $CDK
    Financials

    Live finance-specific insights

    See more
    • CDK Global Declares Regular Quarterly Cash Dividend

      HOFFMAN ESTATES, Ill., June 09, 2022 (GLOBE NEWSWIRE) -- CDK Global, Inc. (NASDAQ:CDK) has declared a regular quarterly cash dividend of $0.15 per share payable on June 29, 2022 to shareholders of record at the close of business on June 20, 2022. About CDK Global With approximately $2 billion in revenues, CDK Global (NASDAQ:CDK) is a leading provider of retail technology and software as a service (SaaS) solutions that help dealers and auto manufacturers run their businesses more efficiently, drive improved profitability and create frictionless purchasing and ownership experiences for consumers. Today, CDK serves over 15,000 retail locations in North America. For more information, visit c

      6/9/22 4:10:00 PM ET
      $CDK
      Retail: Computer Software & Peripheral Equipment
      Technology
    • CDK Global, Inc. Reports Third Quarter Fiscal 2022 Results

      Revenue Growth of 6% Year over Year HOFFMAN ESTATES, Ill., May 05, 2022 (GLOBE NEWSWIRE) -- CDK Global, Inc. (NASDAQ:CDK) today announced financial results for its fiscal 2022 third quarter ended March 31, 2022. Revenue of $459.7 million in the third quarter ended March 31, 2022Revenue growth of 6% year-over-year driven by both core and acquisition related businessesStrong subscription growth due to contributions from site growth, revenue-per-site growth and the increased adoption of modern retail capability at dealershipsGAAP Diluted earnings per share of $0.56; Non-GAAP Adjusted diluted earnings per share of $0.78Adjusted EBITDA year-over-year growth of 5% and EPS growth of 13%

      5/5/22 4:10:00 PM ET
      $CDK
      Retail: Computer Software & Peripheral Equipment
      Technology
    • CDK Global, Inc. Reports Second Quarter Fiscal 2022 Results

      HOFFMAN ESTATES, Ill., Feb. 03, 2022 (GLOBE NEWSWIRE) -- CDK Global, Inc. (NASDAQ:CDK) today announced financial results for its fiscal 2022 second quarter ended December 31, 2021. "We continued to see the benefit of our focus on product innovation and on customer success which resulted in another quarter of solid growth DMS sites and average revenue per site," said Brian Krzanich, CDK chief executive officer. "This growth is coming from both our core business and contributions from recent acquisitions. CDK is uniquely positioned as the center of the automotive retail ecosystem, and through our relentless focus on building connections through our SaaS solutions and investing in our vision

      2/3/22 4:10:00 PM ET
      $CDK
      Retail: Computer Software & Peripheral Equipment
      Technology